Physicians' Academy for Cardiovascular Education

Outcomes of GLP-1 RA in Diabetes & CVD: What are the key opportunities for cardiology practice?

Meeting report with video, highlights and slides of a PACE-CME symposium held during ESC 2018 in Munich on the potential role of GLP-1 RA in cardiology practice - Videos and online CME will be added soon

Translating GLP-1RA trial outcomes to cardiology practice: Which patients will benefit?

10' education - Dec. 10, 2018 - Prof. Lars Rydén, MD - Stockholm Sweden
Different GLP-1RAs have shown different effects in CV outcomes trials. Prof Rydén scrutinizes the results of the trials to learn more about the effects of individual GLP-1RAs and what the differences may originate from.

Different GLP-1RAs have shown different effects in CV outcomes trials. Prof Rydén scrutinizes the results of the trials to learn more about the effects of individual GLP-1RAs and what the differences may originate from.

GLP-1 receptor agonists: The cardiovascular benefits beyond glucose control

10' education - Aug. 27, 2018 - ESC 2018 - Munich, Germany - Filip K. Knop - Copenhagen, Denmark
After considering the incretin effect and how this is impaired in T2DM, prof. Knop sets out how the various effects of GLP-1 receptor agonists can help in management of T2DM.

After considering the incretin effect and how this is impaired in T2DM, prof. Knop sets out how the various effects of GLP-1 receptor agonists can help in management of T2DM.

Diabetes & CVD: Time for a multifactorial approach

10' education - Aug. 27, 2018 - ESC 2018 - Munich, Germany - John E Deanfield, MD - London, United Kingdom
In recent years, new insights into the CV risk associated with diabetes have resulted in a new management approach of T2DM. Prof. Deanfield explains the rationale of a multifactorial approach.

In recent years, new insights into the CV risk associated with diabetes have resulted in a new management approach of T2DM. Prof. Deanfield explains the rationale of a multifactorial approach.

Meeting Impression | Outcomes of GLP-1 RA in Diabetes & CVD

Munich, Germany - August 27, 2018
Munich, Germany - August 27, 2018

Download the meeting impression of this PACE symposium during ESC 2018, that reviewed outcomes of GLP-1 RA in Diabetes & CVD.

Summary | Translating GLP-1 trial outcomes to cardiology practice: Which patients will benefit?

August 27, 2018 – Lars Rydén, MD

This is a summary of the presentation by Lars Rydén, in which he presents which patients will likely benefit from GLP-1RA therapy by discussing differences observed between GLP-1RA trials.

Summary | GLP-1 receptor agonists: The cardiovascular benefits beyond glucose control

August 27, 2018 – Dr. Filip K. Knop, MD, PhD

This is a summary of the presentation by dr. Filip K. Knop, in which he explains that GLP-1RA treatment has also beneficial effects beyond glucose metabolism in T2DM patients.

Summary | Diabetes & CVD: Time for a multifactorial approach

August 27, 2018 – Prof. John E Deanfield, MD

This is a summary of the presentation by prof. John E Deanfield, in which he explains why diabetologists and cardiologists have to collaborate on the care of diabetes patients.

Slides: GLP-1 receptor agonists: The cardiovascular benefits beyond glucose control

Presentation Prof. Filip K Knop

Slides (presentation) - Aug. 27, 2018 - ESC Congress 2018, Munich - Filip K Knop, MD – Copenhagen, Denmark
This lecture by prof. Filip K Knop was part of a CME accredited symposium

Slides as educational service to PACE members and meeting participants

Slides: Diabetes & CVD: Time for a multifactorial approach

Presentation Prof. John Deanfield

Slides (presentation) - Aug. 27, 2018 - ESC Congress 2018, Munich - John Deanfield, MD - London, UK
This lecture by prof. John Deanfield was part of a CME accredited symposium

Slides as educational service to PACE members and meeting participants

Outcomes of GLP-1 RA in Diabetes & CVD: What are the key opportunities for cardiology practice?
Outcomes of GLP-1 RA in Diabetes & CVD: What are the key opportunities for cardiology practice?